Drug in Ozempic may enable patients with newly diagnosed type 1 diabetes to stave off insulin use

(CNN) — A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking

Related Keywords

Toronto ,Ontario ,Canada ,Paresh Dandona ,Daniel Drucker ,Cable News Network Inc ,Discovery Company ,University At Buffalo Jacobs School Of Medicine ,Novo Nordisk ,Warner Bros ,Biomedical Sciences ,Lunenfeld Tanenbaum Research Institute At Mount Sinai Hospital ,Cnn ,New England Journal ,Buffalo Jacobs School ,Lunenfeld Tanenbaum Research Institute ,Mount Sinai Hospital ,Wall Street ,Tandem Diabetes Care ,News Network ,News ,Health ,Ation World ,